Correlation Between Bristol-Myers Squibb and KBS Real

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol-Myers Squibb and KBS Real at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol-Myers Squibb and KBS Real into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and KBS Real Estate, you can compare the effects of market volatilities on Bristol-Myers Squibb and KBS Real and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol-Myers Squibb with a short position of KBS Real. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol-Myers Squibb and KBS Real.

Diversification Opportunities for Bristol-Myers Squibb and KBS Real

-0.76
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Bristol-Myers and KBS is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and KBS Real Estate in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on KBS Real Estate and Bristol-Myers Squibb is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with KBS Real. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of KBS Real Estate has no effect on the direction of Bristol-Myers Squibb i.e., Bristol-Myers Squibb and KBS Real go up and down completely randomly.

Pair Corralation between Bristol-Myers Squibb and KBS Real

Assuming the 90 days horizon Bristol Myers Squibb is expected to generate 0.87 times more return on investment than KBS Real. However, Bristol Myers Squibb is 1.15 times less risky than KBS Real. It trades about 0.15 of its potential returns per unit of risk. KBS Real Estate is currently generating about -0.32 per unit of risk. If you would invest  90,051  in Bristol Myers Squibb on September 4, 2024 and sell it today you would earn a total of  10,504  from holding Bristol Myers Squibb or generate 11.66% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy90.48%
ValuesDaily Returns

Bristol Myers Squibb  vs.  KBS Real Estate

 Performance 
       Timeline  
Bristol Myers Squibb 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile primary indicators, Bristol-Myers Squibb reported solid returns over the last few months and may actually be approaching a breakup point.
KBS Real Estate 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days KBS Real Estate has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Bristol-Myers Squibb and KBS Real Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol-Myers Squibb and KBS Real

The main advantage of trading using opposite Bristol-Myers Squibb and KBS Real positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol-Myers Squibb position performs unexpectedly, KBS Real can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in KBS Real will offset losses from the drop in KBS Real's long position.
The idea behind Bristol Myers Squibb and KBS Real Estate pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Stocks Directory
Find actively traded stocks across global markets